Invega Sustenna News and Research

RSS
Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson announces financial results for the third quarter of 2009

FDA approves Invega Sustenna for schizophrenia

FDA approves Invega Sustenna for schizophrenia